Immucell (ICCC) EBITDA (2010 - 2026)
Immucell (ICCC) recorded EBITDA of $2.41 million in Q2 2026, up 91.9% from $1.25 million a year earlier.
Powered by 
Analysis
Immucell (ICCC) EBITDA (2010 - 2026) Analysis & Trends
On a TTM basis, Immucell's EBITDA came in at $5.05 million as of Jun 30, 2026, up 12.5% year-over-year; for FY2025, it was $4.45 million, up 301.6% from FY2024.
- Annual EBITDA has a five-year compound annual growth rate of 32.5% (FY2020 to FY2025).
- Across earlier years, EBITDA came in at $1.11 million in FY2024, -$2.99 million in FY2023, $215,402 in FY2022 (-92.2%) and $2.75 million in FY2021 (+152.2%).
- The Q2 2026 figure is the highest quarterly EBITDA in data going back to Q3 2010.
- On a year-over-year basis, EBITDA rose in four of the last five quarters, with growth averaging 207.7%.
- Peak year-over-year performance for EBITDA in the last five years was growth of 533.4% in Q3 2025, against a decline of 98.0% in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | 2.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.41 Mn |
| Dec 31, 2025 | 659,449.00 |
| Sep 30, 2025 | 763,096.00 |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 126,614.00 |
| Jun 30, 2024 | -689,260.00 |
| Mar 31, 2024 | 392,471.00 |
| Dec 31, 2023 | 699,849.00 |
| Sep 30, 2023 | -461,485.00 |
| Jun 30, 2023 | -611,086.00 |
| Mar 31, 2023 | -1.59 Mn |
| Dec 31, 2022 | -1.02 Mn |
| Sep 30, 2022 | 24,145.00 |
| Jun 30, 2022 | 18,983.00 |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 753,349.00 |
| Sep 30, 2021 | 895,992.00 |
| Jun 30, 2021 | 844,547.00 |
API Access
Immucell EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();